Relying on superior head bridge industrial park policies and geopolitical advantages, the Group's development focus fell on the first bridge, to build the first bridge strategy: 

         

1. Actively linked with research institutes in collaboration with institutions of higher learning. And Institute of Basic Science of Military Medical Sciences, Chinese Academy of Sciences Institute of the process of union, establish postdoctoral locally, introducing specialized medical equipment, Dr. biotechnology in immune cells, such as nano-silver project implantation cooperate. 

 

2 active cooperation with the National Food and Drug Administration, the introduction of high-tech enterprises have settled down the first bridge, break through the bottleneck in the development of orthopedic medical devices and other direction, creating a chain of high value-added products for the long term development of the first bridge building blocks of medical devices. 

 

3 Group plans to invest 100 million yuan to improve self-phased project. A 30 million to complete the construction of the main building, two 30 million to complete the installation of purification laboratory follow-up, high-tech equipment, personnel and other reserves, three 40 million to complete product development to production of the initial investment.